𝛼SK or Search

ENTITY

Simcere Pharmaceutical (2096 HK)

111

Analysis

Health Care • China

Simcere Pharmaceutical Group is an innovation and R&D-driven pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. It focuses on therapeutic areas such as oncology, central nervous system diseases, autoimmune diseases, and anti-infection, with key products including Sanbexin, Endostar, and Bicun. The company was founded in 1995 and is headquartered in Nanjing, China.

more

Refresh

Exchange Announcement • 13 Oct 2026 18:22

Next Day Disclosure Return

Exchange Announcement • 09 Oct 2026 18:11

Next Day Disclosure Return

Exchange Announcement • 24 Sep 2026 16:34

Notification Letter And Reply Form To Non-Registered Holders: Notice Of Publication Of Interim Report 2026

Exchange Announcement • 24 Sep 2026 16:33

Notification Letter And Reply Form To Registered Shareholders: Notice Of Publication Of Interim Report 2026

Exchange Announcement • 24 Sep 2026 16:32

2026 Interim Report

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x